Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States
Abstract
Curative surgical treatments afford the best prognosis for patients with intrahepatic cholangiocarcinoma (iCCA); however, the comparative effectiveness of treatment options and factors associated with curative treatment receipt for early stage iCCA remain unknown.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 23, 2022
- Source ID
- 10.1002/cncr.34436
Entities
People
- Amit Singal
- Gregory J. Gores
- Irene K. Kim
- Ju Dong Yang
- Julie K. Heimbach
- Kambiz Kosari
- Lewis R. Roberts
- Marc L. Friedman
- Marie Lauzon
- Mazen Noureddin
- Michael Luu
- Nicholas N. Nissen
- Tsuyoshi Todo
- Vatche G. Agopian
- Yi‐te Lee
Organizations
- American College of Gastroenterology
- Cedars-Sinai Medical Center
- Mayo Clinic
- National Institutes of Health
- United States Department of Defense
- University of California
- University of Texas at Austin